# Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis

> **NCT01029405** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 145 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** AN2728
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01029405
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-05
- **Final completion:** 2010-06
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2017-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01029405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01029405, "Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01029405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*